.png0/jcr:content.png)
Inspiration and Innovation
Get inspired and stay on the cutting edge of innovation with these resources.
Campus
- Soliqua®
- For a Peaceful Ramadan
- Soliqua SoliD®
- Soliqua Easy Start®
- Soliqua Guidelines®
- Soliqua Data Set®
- Soliqua Simplicity®
- Soliqua Safety®
- Soliqua®
- Reimbursement
- Meet The Expert
- Soliqua Unmet Needs Video
- Post-GLP Podcast: needs of patients on GLP-1 RA with basal insulin
- Limitations of Premixed Insulin
- Always On
- How to Start People with Diabetes to Toujeo
- Bridging the Glycemic Gap- Timely Transition from OADs to Toujeo
- Evolving Basal Insulin Therapy- From 1st Gen to 2nd Gen
- The Kidney-Diabetes Connection- Clinical Use of Toujeo in Dual Diagnosis
- Toujeo vs Degludec- Clinical Insights from the BRIGHT study for Insulin selection
- Toujeo and GLP1s- Optimising Glycemic Control in Uncontrolled T2D
- New Findings on Toujeo® for T2D Management Following Dual GIP-GLP-1 RA Therapy
Campus
- Soliqua®
- For a Peaceful Ramadan
- Soliqua SoliD®
- Soliqua Easy Start®
- Soliqua Guidelines®
- Soliqua Data Set®
- Soliqua Simplicity®
- Soliqua Safety®
- Soliqua®
- Reimbursement
- Meet The Expert
- Soliqua Unmet Needs Video
- Post-GLP Podcast: needs of patients on GLP-1 RA with basal insulin
- Limitations of Premixed Insulin
- Always On
- How to Start People with Diabetes to Toujeo
- Bridging the Glycemic Gap- Timely Transition from OADs to Toujeo
- Evolving Basal Insulin Therapy- From 1st Gen to 2nd Gen
- The Kidney-Diabetes Connection- Clinical Use of Toujeo in Dual Diagnosis
- Toujeo vs Degludec- Clinical Insights from the BRIGHT study for Insulin selection
- Toujeo and GLP1s- Optimising Glycemic Control in Uncontrolled T2D
- New Findings on Toujeo® for T2D Management Following Dual GIP-GLP-1 RA Therapy